We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Qualasept Ltd t/a Bath ASU is recalling a specific batch of Irinotecan 200mg/260mL in sodium chloride 0.9% w/v intravenous infusion and specific batches of Infliximab (Remsima) Intravenous infusion in Sodium Chloride 0.9%w/v due to risks of reduced product quality.
CMA closes investigation into drug firm MSD’s discount scheme.
The CMA has issued a no grounds for action decision following investigation of discounts offered for Remicade.
The CMA has today issued a statement of objections to the pharmaceutical company Merck Sharp & Dohme Limited (MSD).
Risk of tuberculosis - screen all patients before starting treatment and monitor them closely.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
Product Recall for JOrange Hand-Tie Life Jacket DTS-95-I sold via Amazon presenting a serious risk of drowning.
Check what side effects people have reported when they've taken a medicine.
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
Product Safety Report for Aliex 4-in-1 Montessori Toy presenting a serious risk of choking.
Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Incident planning for potent synthetic opioids arriving into the illicit drug market.
Information for victims and witnesses of crime related to a recent ransomware attack affecting Eurofins Scientific.
The second and concluding report on opioid substitution therapy from the Advisory Council on the Misuse of Drugs (ACMD).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.